C. Bryce

A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer.

K. N., Martin Gleave, Richard Klasa et al. · PubMed · 2001 · 191 citations

Ten-Year Outcomes in a Population-Based Cohort of Node-Negative, Lymphatic, and Vascular Invasion–Negative Early Breast Cancers Without Adjuvant Systemic Therapies

Stephen Chia, Caroline Speers, C. Bryce et al. · Journal of Clinical Oncology · 2004 · 145 citations

Prediction of axillary lymph node involvement of women with invasive breast carcinoma

Ivo A. Olivotto, Jeremy S. H. Jackson, Donna Mates et al. · Cancer · 1998 · 137 citations · Full text

Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence

P Froud, Donna Mates, Jeremy S. H. Jackson et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 111 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +9

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen

Hagen F. Kennecke, Ivo A. Olivotto, Caroline Speers et al. · Annals of Oncology · 2006 · 103 citations · Full text

Late Risk, Breast Oncology, Early Breast Cancer +10